CTMX
Price
$2.12
Change
+$0.04 (+1.92%)
Updated
Sep 3 closing price
Capitalization
349.62M
63 days until earnings call
MDXG
Price
$7.10
Change
-$0.09 (-1.25%)
Updated
Sep 3 closing price
Capitalization
1.05B
55 days until earnings call
Interact to see
Advertisement

CTMX vs MDXG

Header iconCTMX vs MDXG Comparison
Open Charts CTMX vs MDXGBanner chart's image
CytomX Therapeutics
Price$2.12
Change+$0.04 (+1.92%)
Volume$1.53M
Capitalization349.62M
MiMedx Group
Price$7.10
Change-$0.09 (-1.25%)
Volume$448.68K
Capitalization1.05B
CTMX vs MDXG Comparison Chart in %
Loading...
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTMX vs. MDXG commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTMX is a StrongBuy and MDXG is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (CTMX: $2.12 vs. MDXG: $7.10)
Brand notoriety: CTMX and MDXG are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTMX: 60% vs. MDXG: 57%
Market capitalization -- CTMX: $349.62M vs. MDXG: $1.05B
CTMX [@Biotechnology] is valued at $349.62M. MDXG’s [@Biotechnology] market capitalization is $1.05B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTMX’s FA Score shows that 1 FA rating(s) are green whileMDXG’s FA Score has 1 green FA rating(s).

  • CTMX’s FA Score: 1 green, 4 red.
  • MDXG’s FA Score: 1 green, 4 red.
According to our system of comparison, CTMX is a better buy in the long-term than MDXG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTMX’s TA Score shows that 6 TA indicator(s) are bullish while MDXG’s TA Score has 2 bullish TA indicator(s).

  • CTMX’s TA Score: 6 bullish, 2 bearish.
  • MDXG’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CTMX is a better buy in the short-term than MDXG.

Price Growth

CTMX (@Biotechnology) experienced а +2.42% price change this week, while MDXG (@Biotechnology) price change was -0.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.29%. For the same industry, the average monthly price growth was +15.06%, and the average quarterly price growth was +30.89%.

Reported Earning Dates

CTMX is expected to report earnings on Nov 06, 2025.

MDXG is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+0.29% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDXG($1.05B) has a higher market cap than CTMX($350M). MDXG has higher P/E ratio than CTMX: MDXG (33.81) vs CTMX (4.24). CTMX YTD gains are higher at: 105.825 vs. MDXG (-26.195). MDXG has higher annual earnings (EBITDA): 52.7M vs. CTMX (44.7M). CTMX has more cash in the bank: 158M vs. MDXG (119M). CTMX has less debt than MDXG: CTMX (6.89M) vs MDXG (18.5M). MDXG has higher revenues than CTMX: MDXG (364M) vs CTMX (141M).
CTMXMDXGCTMX / MDXG
Capitalization350M1.05B33%
EBITDA44.7M52.7M85%
Gain YTD105.825-26.195-404%
P/E Ratio4.2433.8113%
Revenue141M364M39%
Total Cash158M119M133%
Total Debt6.89M18.5M37%
FUNDAMENTALS RATINGS
CTMX vs MDXG: Fundamental Ratings
CTMX
MDXG
OUTLOOK RATING
1..100
210
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
10090
SMR RATING
1..100
1351
PRICE GROWTH RATING
1..100
3756
P/E GROWTH RATING
1..100
925
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CTMX's Valuation (39) in the Biotechnology industry is in the same range as MDXG (68). This means that CTMX’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's Profit vs Risk Rating (90) in the Biotechnology industry is in the same range as CTMX (100). This means that MDXG’s stock grew similarly to CTMX’s over the last 12 months.

CTMX's SMR Rating (13) in the Biotechnology industry is somewhat better than the same rating for MDXG (51). This means that CTMX’s stock grew somewhat faster than MDXG’s over the last 12 months.

CTMX's Price Growth Rating (37) in the Biotechnology industry is in the same range as MDXG (56). This means that CTMX’s stock grew similarly to MDXG’s over the last 12 months.

MDXG's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for CTMX (92). This means that MDXG’s stock grew significantly faster than CTMX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CTMXMDXG
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 7 days ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
Bearish Trend 15 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CTMX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDXG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TYCMY28.571.11
+4.02%
Tingyi Cayman Islands Holdings Corp.
BCMRF0.07N/A
N/A
BCM Resources Corp.
FACO3.41N/A
N/A
First Acceptance Corp.
ELRXF5.95N/A
N/A
AB Electrolux
DBSDY156.87-0.29
-0.18%
DBS Group Holdings Ltd.

CTMX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CTMX has been loosely correlated with BCAB. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CTMX jumps, then BCAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTMX
1D Price
Change %
CTMX100%
+1.92%
BCAB - CTMX
37%
Loosely correlated
+9.06%
THRD - CTMX
37%
Loosely correlated
N/A
RAPT - CTMX
34%
Loosely correlated
-4.80%
KZR - CTMX
34%
Loosely correlated
+1.57%
FATE - CTMX
33%
Loosely correlated
-2.91%
More

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with INM. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then INM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
-1.25%
INM - MDXG
38%
Loosely correlated
-2.31%
PCVX - MDXG
36%
Loosely correlated
+1.71%
MGNX - MDXG
36%
Loosely correlated
+9.77%
CTMX - MDXG
32%
Poorly correlated
+1.92%
FULC - MDXG
32%
Poorly correlated
+1.72%
More